Yuanxing Gene Technology Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Later Stage VC
- Investors
-
10
Yuanxing Gene Technology General Information
Description
Provider of biopharmaceutical CDMO services specializing in advanced therapy manufacturing intended for biotechnology and pharmaceutical clients. The company offers viral vector manufacturing, induced pluripotent stem cell platforms, mRNA therapy production, process development, analytical testing, and integrated manufacturing support, thereby enabling accelerated development and scalable deployment of cell and gene therapies.
Contact Information
Website
www.yxgene.comCorporate Office
- 3rd Floor, Building 2, Phase III, Yinxing Zhijie, Xinlan Community
- Guanlan Subdistrict, Longhua District
- Shenzhen, Guangdong
- China
Corporate Office
- 3rd Floor, Building 2, Phase III, Yinxing Zhijie, Xinlan Community
- Guanlan Subdistrict, Longhua District
- Shenzhen, Guangdong
- China
Yuanxing Gene Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 13-May-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 20-Jul-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 21-Oct-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 03-Dec-2015 | Completed | Startup | |||
| 1. Spin-Off | 26-Aug-2015 | Completed | Startup |
Yuanxing Gene Technology Patents
Yuanxing Gene Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026228002-A1 | Cell reprogramming composition containing circrna and mirna and use thereof | Pending | 30-Apr-2025 |
Yuanxing Gene Technology Signals
Yuanxing Gene Technology Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CASH Capital | Venture Capital | Minority | ||
| Eastern Link Capital | PE/Buyout | Minority | ||
| Goldport Capital | Venture Capital | Minority | ||
| Green Pine Capital Partners | Venture Capital | Minority | ||
| Oriental Fortune Investment Holdings | Venture Capital | Minority |
Yuanxing Gene Technology Investments (1)
Yuanxing Gene Technology’s most recent deal was a Seed Round with HYKM BioPharm. The deal was made on 30-Apr-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| HYKM BioPharm | 30-Apr-2019 | Seed Round | Biotechnology |
Yuanxing Gene Technology FAQs
-
When was Yuanxing Gene Technology founded?
Yuanxing Gene Technology was founded in 2015.
-
Where is Yuanxing Gene Technology headquartered?
Yuanxing Gene Technology is headquartered in Shenzhen, China.
-
What is the size of Yuanxing Gene Technology?
Yuanxing Gene Technology has 49 total employees.
-
What industry is Yuanxing Gene Technology in?
Yuanxing Gene Technology’s primary industry is Biotechnology.
-
Is Yuanxing Gene Technology a private or public company?
Yuanxing Gene Technology is a Private company.
-
What is Yuanxing Gene Technology’s current revenue?
The current revenue for Yuanxing Gene Technology is .
-
Who are Yuanxing Gene Technology’s investors?
CASH Capital, Eastern Link Capital, Goldport Capital, Green Pine Capital Partners, and Oriental Fortune Investment Holdings are 5 of 10 investors who have invested in Yuanxing Gene Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process